System Transmission

Top Signal

100#1 JOB

Activity

2191Ripe

+952 today

System

Live1m

Terminal Asset View

stockNASDAQ

LXRX

$1.69-1.74%

Lexicon Pharmaceuticals Inc

Neutral

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

47Neutral

Live Analysis Active

Company Mission

Lexicon Pharmaceuticals Inc creates and sells prescription drugs, mainly for conditions like diabetes and heart disease. Doctors prescribe these medications to patients to help manage their health. The company makes money by selling these drugs and partnering with other pharmaceutical firms to develop new treatments.

LXR

Industry Context

This company operates in the pharmaceutical industry, which focuses on developing and selling medications to treat various diseases. It competes with larger drug makers by specializing in niche areas like metabolic disorders. The industry is heavily regulated, requiring extensive testing and approval processes for new drugs.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

68Matrix

Market Momentum

63.1— Holding Steady

Trend Strength

75— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.9x— Normal Volume

Today's Change

-1.74%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing LXRX across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 04:43 AM UTC

As-of As of 2026-03-16T04:28:22.179Z UTC (~15m delay).

Develops drugs for rare diseases like diabetes and cancer, earning revenue from sales and partnerships with larger pharmaceutical companies.

Weekly range is narrowing near $1.50, often a precursor to a significant breakout or breakdown. Watch for price breaking above or below this level.

Volume spiked 3x at $1, indicating potential buyer interest because it coincided with positive news. Monitor if volume stays above average.

Industry trend toward personalized medicine is driving strength, with price holding above $1.50, signaling resilience. Watch for sector recovery in biotech.

Educational only.

Precision Intelligence Model

Live Terminal Stream

Loading chart...